STOCK TITAN

GEIN - GEIN STOCK NEWS

Welcome to our dedicated page for GEIN news (Ticker: GEIN), a resource for investors and traders seeking the latest updates and insights on GEIN stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GEIN's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GEIN's position in the market.

Rhea-AI Summary

On June 17, 2021, Forza Innovations, formerly Genesys Industries, announced the effective implementation of a name change and a 10-for-1 forward stock split, with ticker symbol GEIND changing to FORZ after 20 business days. CEO Johnny Forzani emphasized the split as a measure to broaden the shareholder base and enhance liquidity. Forza Innovations operates in the health-tech wearable sector and has acquired rights to innovative back compression devices aimed at reducing joint stiffness and relieving inflammation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Genesys Industries (OTC Pink: GEIN) is transitioning from precision CNC manufacturing to the health-tech wearable market through the acquisition of WarmUp products, an innovative back compression device. This product aims to alleviate joint stiffness and inflammation using therapeutic heat. Leadership changes include John Forzani taking over as CEO following Shefali Vibhakar's resignation. The company is also working to update its financial filings with the SEC and engage an auditor for the year ending June 30, 2020, which is expected soon.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
GEIN

OTC:GEIN

GEIN Rankings

GEIN Stock Data